Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$33.4 - $45.2 $6,680 - $9,040
-200 Reduced 3.48%
5,539 $196,000
Q4 2023

Feb 08, 2024

SELL
$34.21 - $44.59 $8,860 - $11,548
-259 Reduced 4.32%
5,739 $249,000
Q3 2023

Oct 30, 2023

SELL
$37.8 - $45.97 $13,192 - $16,043
-349 Reduced 5.5%
5,998 $229,000
Q2 2023

Aug 07, 2023

SELL
$37.95 - $58.98 $7,058 - $10,970
-186 Reduced 2.85%
6,347 $261,000
Q1 2023

Apr 27, 2023

SELL
$52.61 - $60.49 $5,261 - $6,049
-100 Reduced 1.51%
6,533 $375,000
Q3 2022

Oct 28, 2022

BUY
$42.28 - $57.17 $5,200 - $7,031
123 Added 1.89%
6,633 $281,000
Q2 2021

Aug 10, 2021

SELL
$66.79 - $76.63 $6,679 - $7,663
-100 Reduced 1.51%
6,510 $444,000
Q1 2021

May 10, 2021

SELL
$62.63 - $71.15 $6,263 - $7,115
-100 Reduced 1.49%
6,610 $457,000
Q4 2020

Feb 08, 2021

SELL
$43.31 - $66.55 $7,102 - $10,914
-164 Reduced 2.39%
6,710 $436,000
Q3 2020

Nov 04, 2020

SELL
$43.33 - $51.72 $11,179 - $13,343
-258 Reduced 3.62%
6,874 $325,000
Q2 2020

Aug 06, 2020

SELL
$41.42 - $55.57 $5,508 - $7,390
-133 Reduced 1.83%
7,132 $335,000
Q4 2019

Feb 04, 2020

SELL
$55.73 - $62.49 $39,178 - $43,930
-703 Reduced 8.82%
7,265 $423,000
Q3 2019

Nov 12, 2019

SELL
$53.29 - $64.59 $29,416 - $35,653
-552 Reduced 6.48%
7,968 $479,000
Q2 2019

Aug 05, 2019

SELL
$46.45 - $55.85 $1,486 - $1,787
-32 Reduced 0.37%
8,520 $476,000
Q4 2018

Feb 04, 2019

SELL
$42.62 - $64.51 $4,262 - $6,451
-100 Reduced 1.16%
8,552 $386,000
Q3 2018

Oct 26, 2018

SELL
$57.63 - $65.87 $6,627 - $7,575
-115 Reduced 1.31%
8,652 $570,000
Q2 2018

Aug 09, 2018

BUY
$54.05 - $67.23 $473,856 - $589,405
8,767 New
8,767 $565,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.